Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CZC-25146 (CHEMBL2397014) is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 117.00 | |
25 mg | In stock | $ 253.00 | |
50 mg | In stock | $ 458.00 | |
100 mg | In stock | $ 673.00 | |
500 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 75.00 |
Description | CZC-25146 (CHEMBL2397014) is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively. |
Targets&IC50 | LRRK2 (G2019S):6.87 nM, LRRK2:4.76 nM |
Synonyms | CHEMBL2397014 |
Molecular Weight | 488.54 |
Formula | C22H25FN6O4S |
CAS No. | 1191911-26-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 46 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CZC-25146 1191911-26-8 Autophagy LRRK2 CHEMBL2397014 Leucine-rich repeat kinase 2 Parkinson's disease Inhibitor CZC 25146 liver diseases CZC25146 CHEMBL 2397014 inhibit CHEMBL-2397014 neurons inflammatory LRRK2 G2019S inhibitor